Psoriatic Arthritis
Conference Coverage
EADV: Pursuing ‘clear’ in psoriasis worthwhile, expert says
A Physician Global Assessment of “clear” is worth striving for in psoriasis patients because it represents a clinically important lesser level of...
News
Anti-TNF therapy can continue for IBD patients with skin lesions
News
Steroid use down, biologic use rising in pregnancies of women with rheumatic disease
Key clinical point: Women with lupus and other rheumatic diseases used fewer steroids during pregnancy over a 12-year period, while use of...
News
Psoriasis cohort reveals high arthritis risk
Key clinical point: Incidence of psoriatic arthritis is higher among psoriasis patients than previously estimated.
Conference Coverage
EADV: New long-term data on biologics for pediatric psoriasis ‘encouraging’
The 1- and 5-year outcomes for adalimumab and etanercept in pediatric psoriasis are reassuring.
Conference Coverage
EADV: Pediatric psoriasis called ‘grossly undertreated’
Most dermatologists are reluctant to use systemic therapies for moderate to severe pediatric psoriasis, but study investigators say this is not...
Conference Coverage
ACR: Cardiovascular risk factors in psoriatic diseases are common, often go untreated
Key clinical point: Patients with psoriatic diseases have high rates of modifiable cardiovascular risk factors that often go untreated, based on...
Conference Coverage
State laws, regulatory concerns complicate biosimilars landscape
Conference Coverage
VIDEO: Psoriasis, psoriatic arthritis improve with bariatric surgery
Conference Coverage
Shingles vaccine protection lasted 5-6 years in autoimmune disease patients
Key clinical point: Protection against shingles appeared to wane between the fifth and sixth years after patients with autoimmune diseases...
Conference Coverage
Stroke risk rose in autoimmune disease patients after herpes zoster
Key clinical point: Stroke risk increased by 50% in the month after patients with autoimmune diseases had an episode of herpes zoster. Major...